EDWARDS LIFESCIENCES CORPORATION (EW) FY2024 YTD Q3 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2024-01-01 to 2024-09-30

Swipe to see the full flow
EDWARDS LIFESCIENCES CORPORATION cash flow reconciliation, Jan 1, 2024 through Sep 30, 2024One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $669,800,000.00Net income → Operating adjustments reconciliation: $3,115,600,000.00Income taxes → Operating adjustments reconciliation: $301,800,000.00Stock-based compensation → Operating adjustments reconciliation: $130,600,000.00Depreciation and amortization → Operating adjustments reconciliation: $112,600,000.00Accounts payable and accrued liabilities → Operating adjustments reconciliation: $92,600,000.00Prepaid expenses and other current assets → Operating adjustments reconciliation: $27,400,000.00Non-cash operating lease cost → Operating adjustments reconciliation: $21,600,000.00Accounts and other receivables, net → Operating adjustments reconciliation: $15,300,000.00Long-term prepaid royalties (Note 3) → Operating adjustments reconciliation: $6,200,000.00Other → Operating adjustments reconciliation: $2,700,000.00Operating adjustments reconciliation → Gain on sale of business (Note 5): $3,337,400,000.00Operating adjustments reconciliation → Deferred income taxes: $224,900,000.00Operating adjustments reconciliation → Inventories: $204,900,000.00Operating adjustments reconciliation → Gain on remeasurement of previously held interest upon acquisition (Note 8): $24,600,000.00Operating adjustments reconciliation → Intellectual property agreement accrual: $24,300,000.00Operating adjustments reconciliation → Other: $10,300,000.00Proceeds from sale of business → investing reconciliation: $3,927,400,000.00Proceeds from available-for-sale investments (Note 6) → investing reconciliation: $539,100,000.00Proceeds from held-to-maturity investments (Note 6) → investing reconciliation: $50,400,000.00investing reconciliation → Net cash from investing activities: $2,889,600,000.00investing reconciliation → Business combination, net of cash: $763,600,000.00investing reconciliation → Purchases of available-for-sale investments (Note 6): $518,800,000.00investing reconciliation → Capital expenditures: $202,600,000.00investing reconciliation → Other: $36,400,000.00investing reconciliation → Purchases of held-to-maturity investments (Note 6): $36,300,000.00investing reconciliation → Issuances of notes receivable: $28,000,000.00investing reconciliation → Investments in intangible assets: $25,400,000.00investing reconciliation → Payment for acquisition options (Note 7): $16,200,000.00Net cash used in financing activities → financing reconciliation: $1,011,600,000.00Proceeds from stock plans → financing reconciliation: $150,900,000.00financing reconciliation → Purchases of treasury stock: $1,059,300,000.00financing reconciliation → Equity forward contract related to accelerated share repurchase agreement (Note 12): $100,000,000.00financing reconciliation → Other: $3,200,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $1,148,000,000.00Net cash from operating activities → Cash sources and uses: $669,800,000.00Net cash from investing activities → Cash sources and uses: $2,889,600,000.00Cash sources and uses → Exchange-rate effect: $12,400,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $3,683,400,000.00Cash sources and uses → Net cash used in financing activities: $1,011,600,000.00Deferred income taxes: -$224,900,000.00Deferred tax balances−$224.90 MGain on remeasurement of previously held interest upon acquisition (Note 8): -$24,600,000.00Stake remeasurement gain & loss−$24.60 MGain on sale of business (Note 5): -$3,337,400,000.00Business sale gain & loss−$3.34 BInventories: -$204,900,000.00Inventories−$204.90 MIntellectual property agreement accrual: -$24,300,000.00Intellectual property accrual−$24.30 MNon-cash operating lease cost: $21,600,000.00Operating lease amortization+$21.60 MStock-based compensation: $130,600,000.00Stock-based compensation+$130.60 MChange in fair value of contingent consideration liabilities (Note 9): $0.00Net income: $3,785,400,000.00Net income+$3.79 BDepreciation and amortization: $112,600,000.00Depreciation & amortization+$112.60 MAccounts and other receivables, net: $15,300,000.00Accounts & other receivables+$15.30 MIncome taxes: $301,800,000.00Income taxes payable+$301.80 MOther: -$10,300,000.00Other working capital, net−$10.30 MPrepaid expenses and other current assets: $27,400,000.00Prepaid & other assets+$27.40 MAccounts payable and accrued liabilities: $92,600,000.00Payables & accrued liabilities+$92.60 MLong-term prepaid royalties (Note 3): $6,200,000.00Long-term prepaid royalties (Note 3)+$6.20 MOther: $2,700,000.00Other non-cash items+$2.70 MNet cash from operating activities: $669,800,000.00Operating cash+$669.80 MOperating adjustments reconciliation: $3,826,400,000.00Other: -$3,200,000.00Other financing, net−$3.20 MProceeds from stock plans: $150,900,000.00Stock plan proceeds+$150.90 MPurchases of treasury stock: -$1,059,300,000.00Common stock repurchases−$1.06 BEquity forward contract related to accelerated share repurchase agreement (Note 12): -$100,000,000.00Accelerated repurchase forward−$100.00 MNet cash used in financing activities: -$1,011,600,000.00. Cash required to fund net payments.Financing cash−$1.01 Bfinancing reconciliation: $1,162,500,000.00Capital expenditures: -$202,600,000.00PP&E purchases−$202.60 MPayment for acquisition options (Note 7): -$16,200,000.00Payment for acquisition options (Note 7)−$16.20 MInvestments in intangible assets: -$25,400,000.00Intangible asset purchases−$25.40 MProceeds from available-for-sale investments (Note 6): $539,100,000.00AFS securities proceeds+$539.10 MProceeds from sale of business: $3,927,400,000.00Business sales+$3.93 BOther: -$36,400,000.00Other investing, net−$36.40 MIssuances of notes receivable: -$28,000,000.00Issuances of notes receivable−$28.00 MProceeds from held-to-maturity investments (Note 6): $50,400,000.00HTM sales & maturities+$50.40 MPurchases of available-for-sale investments (Note 6): -$518,800,000.00AFS securities purchases−$518.80 MBusiness combination, net of cash: -$763,600,000.00Acquisitions, net of cash−$763.60 MPurchases of held-to-maturity investments (Note 6): -$36,300,000.00HTM securities purchases−$36.30 MNet cash from investing activities: $2,889,600,000.00Investing cash+$2.89 Binvesting reconciliation: $4,516,900,000.00Cash sources and uses: $4,707,400,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $1,148,000,000.00Beginning cash$1.15 BEnding cash: Cash, cash equivalents, and restricted cash: $3,683,400,000.00Ending cash$3.68 BExchange-rate effect: -$12,400,000.00FX effect−$12.40 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$467.20 MOperating cash − cash spent on PP&ECash flow / Net income0.18×Operating cash flow ÷ net incomeNet cash change+$2.54 BEnding cash − beginning cash
Chart details

EDWARDS LIFESCIENCES CORPORATION cash flow reconciliation, Jan 1, 2024 through Sep 30, 2024

Cash flows for Jan 1, 2024 through Sep 30, 2024. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2023. Ending cash: Sep 30, 2024. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2023
1,148,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
669,800,000 US dollars. Net cash provided.
Deferred income taxes
negative 224,900,000 US dollars
Gain on remeasurement of previously held interest upon acquisition (Note 8)
negative 24,600,000 US dollars
Gain on sale of business (Note 5)
negative 3,337,400,000 US dollars
Inventories
negative 204,900,000 US dollars
Intellectual property agreement accrual
negative 24,300,000 US dollars
Non-cash operating lease cost
21,600,000 US dollars
Stock-based compensation
130,600,000 US dollars
Change in fair value of contingent consideration liabilities (Note 9)
0 US dollars
Net income
3,785,400,000 US dollars
Depreciation and amortization
112,600,000 US dollars
Accounts and other receivables, net
15,300,000 US dollars
Income taxes
301,800,000 US dollars
Other
negative 10,300,000 US dollars
Prepaid expenses and other current assets
27,400,000 US dollars
Accounts payable and accrued liabilities
92,600,000 US dollars
Long-term prepaid royalties (Note 3)
6,200,000 US dollars
Other
2,700,000 US dollars
Investing activities
2,889,600,000 US dollars. Net cash provided.
Capital expenditures
negative 202,600,000 US dollars
Payment for acquisition options (Note 7)
negative 16,200,000 US dollars
Investments in intangible assets
negative 25,400,000 US dollars
Proceeds from available-for-sale investments (Note 6)
539,100,000 US dollars
Proceeds from sale of business
3,927,400,000 US dollars
Other
negative 36,400,000 US dollars
Issuances of notes receivable
negative 28,000,000 US dollars
Proceeds from held-to-maturity investments (Note 6)
50,400,000 US dollars
Purchases of available-for-sale investments (Note 6)
negative 518,800,000 US dollars
Business combination, net of cash
negative 763,600,000 US dollars
Purchases of held-to-maturity investments (Note 6)
negative 36,300,000 US dollars
Financing activities
negative 1,011,600,000 US dollars. Net cash used.
Other
negative 3,200,000 US dollars
Proceeds from stock plans
150,900,000 US dollars
Purchases of treasury stock
negative 1,059,300,000 US dollars
Equity forward contract related to accelerated share repurchase agreement (Note 12)
negative 100,000,000 US dollars
Operating adjustment reconciliation
3,826,400,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
1,162,500,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
4,516,900,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 12,400,000 US dollars
Ending cash on Sep 30, 2024
3,683,400,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
4,707,400,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
2,535,400,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.18×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
669,800,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
202,600,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
467,200,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $669.80M of net income directly to operating cash and $3.12B to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 669,800,000 US dollars minus 202,600,000 US dollars equals 467,200,000 US dollars.
EDWARDS LIFESCIENCES CORPORATION (EW) FY2024 YTD Q3 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!